Banner
Workflow

Why latest mpox outbreak is ‘emergency of international concern’

Why latest mpox outbreak is ‘emergency of international concern’
Contact Counsellor

Why latest mpox outbreak is ‘emergency of international concern’

  • Mpox, previously known as monkeypox, has re-emerged as a significant global health threat, prompting the World Health Organization (WHO) to declare it a Public Health Emergency of International Concern (PHEIC).
  • This declaration underscores the severity of the ongoing outbreak and the potential for it to spread further.

What is Mpox?

  • Mpox is a viral infection caused by the mpox virus (MPXV).
  • The disease is characterized by symptoms such as fever, headache, muscle aches, back pain, low energy, swollen lymph nodes, and pox-like rashes.
  • While typically self-limiting, the infection can be fatal, especially among children and immunocompromised individuals.
  • Mpox has been reported in humans since 1970, primarily affecting regions in Africa where the virus was endemic.
  • The global outbreak between July 2022 and May 2023 marked a significant shift, with the disease spreading beyond its usual geographic confines.

New Clade and Transmission

  • The current alarm has been raised due to the emergence of clade Ib of the mpox virus, which is being predominantly transmitted through sexual contact.
  • This is a departure from the traditional zoonotic transmission of the virus (from animals to humans).
  • ver 100 cases of clade Ib have been reported in countries neighboring the Democratic Republic of Congo (DRC), including Burundi, Kenya, Rwanda, and Uganda.
  • These countries had not reported mpox cases prior to this outbreak.

Global and National Response

  • The WHO’s Strategic Advisory Group of Experts on Immunization has recommended at least two vaccines for mpox.
  • An Emergency Use Listing for these vaccines was recently triggered, facilitating faster access for lower-income countries.
  • The WHO's listing allows organizations like GAVI and UNICEF to procure and distribute vaccines to countries that have not yet approved them at the national level.

Implications for India

  • India is at risk of mpox spread, particularly given the global interconnectedness through travel.
  • During the 2022 outbreak, India reported 27 laboratory-confirmed cases and one death, primarily linked to international travel.
  • However, there were also cases in Delhi with no travel history, indicating local transmission.

Preventive Measures

  • Given the potential for the more contagious clade Ib to reach India, it is essential to strengthen surveillance, ensure public awareness, and prepare for possible vaccine distribution.
  • The spread of a new, more transmissible strain of the mpox virus, particularly in Africa, highlights the need for a coordinated international response.
  • The WHO Director-General has emphasized the urgency of addressing the crisis to prevent a repeat of the 2022 global outbreak.
  • The current situation presents an opportunity for global health bodies to improve preparedness and response mechanisms for infectious diseases, especially those originating in regions with limited healthcare infrastructure.

Categories